Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

Global Newswire by Notified: M&A

SEPTEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., SAN DIEGO, Sept.

Pharmaceutical 40

Pharmaceutical Acquisitions Business 40

Global Newswire by Notified: M&A

JULY 2, 2024

July 02, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. a Cayman Islands corporation and special purpose acquisition company (Nasdaq: DECA, “SPAC”), today announced the signing of a letter of intent for a proposed business combination, which provides for a pre-transaction equity value of Semnur up to $2.0 PALO ALTO, Calif.,

Pharmaceutical 72

Pharmaceutical Acquisitions Capital Business 72

Global Newswire by Notified: M&A

MAY 1, 2024

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries.

Pharmaceutical 40

Pharmaceutical Shares Acquisitions 40

Global Newswire by Notified: M&A

OCTOBER 9, 2024

Cergy, 9 October 2024 - SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 88% of Spefinox, an expert player in industrial processes for the agri-food, cosmetics and pharmaceuticals sectors.

Acquisitions 52

Acquisitions Pharmaceutical Food 52

Global Newswire by Notified: M&A

JULY 31, 2024

Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of RSDL ® (Reactive Skin Decontamination Lotion) kit from Emergent BioSolutions Inc. NYSE: EBS) for an up-front payment of approximately $75 million.

Pharmaceutical 40

Pharmaceutical Acquisitions Medical Manufacturing 40

JD Supra: Mergers

OCTOBER 2, 2024

The UK DMCC forms part of a global trend to focus merger review increasingly on vertical concerns and concerns about eliminating nascent competition, including by so-called “killer acquisitions” of firms perceived as future competitive threats. The reforms are particularly relevant to the technology and pharmaceutical.

Mergers and Acquisitions 155

Mergers and Acquisitions Pharmaceutical Mergers Acquisitions 155

JD Supra: Mergers

SEPTEMBER 4, 2024

August 01, 2024: SEAM Group, a B2B business products and services company that provides safety, reliability, maintenance, and enterprise asset management services in the hospitality, food processing, and pharmaceutical industries, was acquired by ABB for an undisclosed amount.

M&A 167

M&A Hospitality Asset Management Pharmaceutical 167

Global Newswire by Notified: M&A

JULY 14, 2024

July 15, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that its previously announced acquisition by the global pharmaceutical company, AstraZeneca, has closed.

Acquisitions 49

Acquisitions Pharmaceutical IT 49

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

MARCH 27, 2024

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc.

Pharmaceutical 40

Pharmaceutical Equities Acquisitions IT 40

Global Newswire by Notified: M&A

SEPTEMBER 21, 2023

21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced today the completion of their acquisition of Paratek Pharmaceuticals, Inc. CAMBRIDGE, Mass.,

Pharmaceutical 40

Pharmaceutical Capital Acquisitions 40

Global Newswire by Notified: M&A

SEPTEMBER 25, 2023

25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. NASDAQ: REGN ) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., TARRYTOWN, N.Y., strengthening the company’s gene therapy and auditory programs.

Acquisitions 85

Acquisitions Pharmaceutical IT 85

Global Newswire by Notified: M&A

OCTOBER 6, 2023

PRESIDIO PROPERTY TRUST ANNOUNCES CLOSING OF MERGER OF ITS SPONSORED SPAC MURPHY CANYON ACQUISITION CORP NOW TRADING AS CONDUIT PHARMACEUTICALS.

Pharmaceutical 40

Pharmaceutical Mergers and Acquisitions Mergers Trading 40

Deal Lawyers

OCTOBER 4, 2024

Alexion Pharmaceuticals, Inc. — both involving acquisitions of development-stage biotech companies and both interpreting an earnout provision’s objective or outward-facing definition of “commercially reasonable efforts.” and Himawan v. Cephalon, Inc.

Pharmaceutical 100

Pharmaceutical Acquisitions 100

Global Newswire by Notified: M&A

SEPTEMBER 4, 2024

Olon, the leading chemical-pharmaceutical group in the production and development of active pharmaceutical ingredients (APIs) and part of the holding company P&R, continues its growth path and announces a new venture: it will acquire HuvePharma Italia Srl and its site in Garessio, (Cuneo, Italy) with a significant increase in its total production (..)

Pharmaceutical 52

Pharmaceutical IT Acquisitions 52

Global Newswire by Notified: M&A

JULY 31, 2023

July 31, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. CORONA, Calif.,

Acquisitions 75

Acquisitions Pharmaceutical Corporation IT 75

JD Supra: Mergers

JANUARY 22, 2024

Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. The timing of the announcement coincided with the start of the 42nd Annual J.P. By: Knobbe Martens

Pharmaceutical 177

Pharmaceutical Healthcare Corporation Equities 177

Global Newswire by Notified: M&A

NOVEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. VANCOUVER, British Columbia, Nov.

Pharmaceutical 49

Pharmaceutical Equities IT Negotiation 49

Global Newswire by Notified: M&A

JUNE 18, 2024

(TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé ("Virage"), a company specializing in the manufacturing and marketing of natural health products ("NHPs"), based in Lévis, Quebec.

Acquisitions 40

Acquisitions Pharmaceutical Manufacturing IT 40

Global Newswire by Notified: M&A

OCTOBER 4, 2023

04, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. Harmony”) and its wholly owned subsidiary, Xylophone Acquisition Corp. Purchaser”), to purchase all outstanding shares of Zynerba common stock. The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.

Pharmaceutical 40

Pharmaceutical Shares Stock Acquisitions 40

JD Supra: Mergers

MAY 26, 2023

s (Amgen) proposed acquisition of Horizon Therapeutics plc (Horizon). On May 17, 2023, the Federal Trade Commission (FTC) challenged Amgen Inc.’s The complaint is significant in three respects. By: Wilson Sonsini Goodrich & Rosati

Mergers 130

Mergers Pharmaceutical Trading Acquisitions 130

Global Newswire by Notified: M&A

JANUARY 10, 2024

10, 2024 (GLOBE NEWSWIRE) -- Evaluate , a Norstella company, announced today the acquisition of J+D Forecasting , a leading provider of forecasting solutions for the pharmaceutical industry. London, UK & Boston, MA, Jan.

Acquisitions 40

Acquisitions Pharmaceutical 40

Global Newswire by Notified: M&A

OCTOBER 31, 2024

PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being.

Pharmaceutical 40

Pharmaceutical Acquisitions 40

The Guardian: Mergers & Acquisitions

MARCH 19, 2024

The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy.

Pharmaceutical 95

Pharmaceutical Portfolio Acquisitions Business 95

Global Newswire by Notified: M&A

JULY 3, 2023

Strategic Acquisition Helps Build Tonix’s Commercial Capabilities and Infrastructure Ahead of Potential Launch of TNX-102 SL for the Management of Fibromyalgia

Acquisitions 40

Acquisitions Pharmaceutical Management 40

Global Newswire by Notified: M&A

DECEMBER 5, 2023

Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment

Acquisitions 45

Acquisitions Pharmaceutical Portfolio 45

Global Newswire by Notified: M&A

SEPTEMBER 26, 2023

OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired: CHINO HILLS, Calif., 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc.

Pharmaceutical 102

Pharmaceutical IT Manufacturing Acquisitions 102

The Guardian: Mergers & Acquisitions

DECEMBER 26, 2023

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmaker AstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market.

Pharmaceutical 84

Pharmaceutical Acquisitions IT Mergers and Acquisitions 84

Solganick & Co.

SEPTEMBER 2, 2024

September 2, 2024 – The software mergers and acquisitions (M&A) marketplace has been bustling with activity in the first half of 2024, reflecting the sector’s robust growth and strategic consolidations. billion acquisition of Ansys, a move aimed at bolstering its software capabilities and expanding its market footprint.

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52

Global Newswire by Notified: M&A

NOVEMBER 20, 2023

20, 2023 (GLOBE NEWSWIRE) -- Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is pleased to announce its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB.

Pharmaceutical 40

Pharmaceutical IT Electronics Manufacturing 40

Global Newswire by Notified: M&A

JUNE 24, 2024

Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approximately.

Pharmaceutical 45

Pharmaceutical Business Acquisitions 45

Global Newswire by Notified: M&A

AUGUST 7, 2024

07, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of ACEFE, S.A.U. ACEFESA” or the “Company”), a Barcelona-based distributor of laboratory consumables and equipment for the biotechnology, molecular biology, pharmaceutical and veterinary industries. LOS ANGELES, Aug.

Pharmaceutical 49

Pharmaceutical Portfolio Acquisitions IT 49

Global Newswire by Notified: M&A

MARCH 5, 2024

Formed through the combination of two legacy animal health providers (Fujita Pharmaceutical Co. and Kyoto Biken Laboratories Inc.) under the stewardship of ORIX Corporation, Sasaeah generates annual revenues of about €75 million, of which 50% from vaccines.

Pharmaceutical 52

Pharmaceutical Manufacturing Portfolio Acquisitions 52

Global Newswire by Notified: M&A

NOVEMBER 27, 2023

27, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Scientific Support Services Ltd (“SSS” or the “Company”), a UK based provider of scientific instruments, supplies and services to customers in the petrochemical, environmental, pharmaceutical, clinical, and food and flavors sectors.

Pharmaceutical 80

Pharmaceutical Food Acquisitions IT 80

Global Newswire by Notified: M&A

SEPTEMBER 20, 2023

Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets. Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets.

Pharmaceutical 52

Pharmaceutical Portfolio Acquisitions 52

Global Newswire by Notified: M&A

JANUARY 19, 2024

million, further to the previously-announced non-binding letter of intent (the “LOI”) for the Company to acquire the Target Company (the “Acquisition”). TEL AVIV, Israel, Jan. 19, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd.

Acquisitions 49

Acquisitions Pharmaceutical IT 49